Jacqueline Gardner‐Nix

600 total citations
11 papers, 410 citations indexed

About

Jacqueline Gardner‐Nix is a scholar working on Anesthesiology and Pain Medicine, Cognitive Neuroscience and Pharmacology. According to data from OpenAlex, Jacqueline Gardner‐Nix has authored 11 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Anesthesiology and Pain Medicine, 6 papers in Cognitive Neuroscience and 5 papers in Pharmacology. Recurrent topics in Jacqueline Gardner‐Nix's work include Pain Management and Opioid Use (7 papers), Pain Management and Placebo Effect (6 papers) and Musculoskeletal pain and rehabilitation (5 papers). Jacqueline Gardner‐Nix is often cited by papers focused on Pain Management and Opioid Use (7 papers), Pain Management and Placebo Effect (6 papers) and Musculoskeletal pain and rehabilitation (5 papers). Jacqueline Gardner‐Nix collaborates with scholars based in Canada, United Kingdom and United States. Jacqueline Gardner‐Nix's co-authors include B Goldman, Dwight E. Moulin, Roman D Jovey, Mary Lynch, Helen Hays, Charles D. Kassardjian, Alessandra Graziottin, G. T. D. Thomson, Paul M. Peloso and W. Bensen and has published in prestigious journals such as Journal of Pain and Symptom Management, Journal of Pain and Clinical Therapeutics.

In The Last Decade

Jacqueline Gardner‐Nix

11 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacqueline Gardner‐Nix Canada 9 173 161 145 93 89 11 410
Roman D Jovey Canada 7 159 0.9× 289 1.8× 150 1.0× 43 0.5× 103 1.2× 8 543
S. Fatima Lakha Canada 10 119 0.7× 240 1.5× 112 0.8× 32 0.3× 74 0.8× 32 414
Valerie Hruschak United States 12 98 0.6× 144 0.9× 179 1.2× 71 0.8× 42 0.5× 26 448
John Sellinger United States 14 130 0.8× 342 2.1× 136 0.9× 81 0.9× 55 0.6× 25 574
Gerald M. Aronoff United States 13 195 1.1× 337 2.1× 102 0.7× 47 0.5× 130 1.5× 36 608
Karen Rubinstein United States 4 114 0.7× 118 0.7× 271 1.9× 28 0.3× 106 1.2× 5 536
Eberhard A. Lux Germany 9 136 0.8× 262 1.6× 68 0.5× 52 0.6× 80 0.9× 37 539
Christopher Spevak United States 8 122 0.7× 88 0.5× 150 1.0× 28 0.3× 68 0.8× 32 369
S. Gritzner Canada 8 76 0.4× 115 0.7× 130 0.9× 74 0.8× 97 1.1× 12 352
Ben Lippe United States 3 124 0.7× 372 2.3× 111 0.8× 63 0.7× 69 0.8× 4 573

Countries citing papers authored by Jacqueline Gardner‐Nix

Since Specialization
Citations

This map shows the geographic impact of Jacqueline Gardner‐Nix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline Gardner‐Nix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline Gardner‐Nix more than expected).

Fields of papers citing papers by Jacqueline Gardner‐Nix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline Gardner‐Nix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline Gardner‐Nix. The network helps show where Jacqueline Gardner‐Nix may publish in the future.

Co-authorship network of co-authors of Jacqueline Gardner‐Nix

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline Gardner‐Nix. A scholar is included among the top collaborators of Jacqueline Gardner‐Nix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline Gardner‐Nix. Jacqueline Gardner‐Nix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Graziottin, Alessandra, et al.. (2011). Opioids: How to Improve Compliance and Adherence. Pain Practice. 11(6). 574–581. 28 indexed citations
3.
4.
Kassardjian, Charles D., et al.. (2008). Validating PRISM (Pictorial Representation of Illness and Self Measure) as a Measure of Suffering in Chronic Non-Cancer Pain Patients. Journal of Pain. 9(12). 1135–1143. 42 indexed citations
5.
Gardner‐Nix, Jacqueline, et al.. (2008). Evaluating distance education of a mindfulness-based meditation programme for chronic pain management. Journal of Telemedicine and Telecare. 14(2). 88–92. 92 indexed citations
6.
Beaulieu, André, Paul M. Peloso, W. Bensen, et al.. (2007). A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain. Clinical Therapeutics. 29(1). 49–60. 39 indexed citations
7.
Gardner‐Nix, Jacqueline. (2004). Chronic Noncancer Pain Management in Older Adults. 1 indexed citations
8.
Jovey, Roman D, Jacqueline Gardner‐Nix, B Goldman, et al.. (2003). Use of Opioid Analgesics for the Treatment of Chronic Noncancer Pain ‐ A Consensus Statement and Guidelines from the Canadian Pain Society, 2002. Pain Research and Management. 8(A). 3A–28A. 103 indexed citations
9.
Gardner‐Nix, Jacqueline. (2003). Principles of opioid use in chronic noncancer pain.. PubMed. 169(1). 38–43. 30 indexed citations
10.
Gardner‐Nix, Jacqueline, B Goldman, Helen Hays, et al.. (1998). Use of Opioid Analgesics for the Treatment of Chronic Noncancer Pain ‐ A Consensus Statement and Guidelines from the Canadian Pain Society. Pain Research and Management. 3(4). 197–208. 21 indexed citations
11.
Gardner‐Nix, Jacqueline. (1996). Oral methadone for managing chronic nonmalignant pain. Journal of Pain and Symptom Management. 11(5). 321–328. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roman D Jovey Breakdown of academic impact, for papers by S. Fatima Lakha Breakdown of academic impact, for papers by Valerie Hruschak Breakdown of academic impact, for papers by John Sellinger Breakdown of academic impact, for papers by Gerald M. Aronoff Breakdown of academic impact, for papers by Karen Rubinstein Breakdown of academic impact, for papers by Eberhard A. Lux Breakdown of academic impact, for papers by Christopher Spevak Breakdown of academic impact, for papers by S. Gritzner Breakdown of academic impact, for papers by Ben Lippe
Rankless by CCL
2026